LSE:DXRX

Diaceutics PLC · LSE · Healthcare · GBP · FY for 2025

Figures on this page computed 2026-11-08 13:03 UTC

Last close

n/aGBp

Market data

1822.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed
- Computed from the filing for 2025
0.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
0.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
3.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed

Price is the furthest below its sector's middle: 0.16 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

838

2016-12-31 to 2025-12-31100 at the start838

Sales: 100.00 on 2016-12-31 to 837.65 on 2025-12-31, up 738%.

Profit

13.0

2016-12-31 to 2025-12-31100 at the start13.0

Profit: 100.00 on 2016-12-31 to 12.98 on 2025-12-31, down 87%.

Shares in issue

122

2016-12-31 to 2025-12-31100 at the start122

Shares in issue: 100.00 on 2016-12-31 to 122.34 on 2025-12-31, up 22%.

Sales is at 838, Profit is at 13, Shares in issue is at 122, against 100 in 2016.

Sales is at 838, Profit is at 13, Shares in issue is at 122, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100838
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Profit, where the first year is 10013
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP
Shares in issue, where the first year is 100122
Source
computed
Statement
income
Fiscal year
2025
Reported in
GBP